Summary of findings: Molecular‐targeted therapy plus chemotherapy vs chemotherapy alone
Adverse event (any) Duration of · people with advanced gastric cancer
Summary of findings: Molecular‐targeted therapy plus chemotherapy probably leads to higher adverse event (any) Duration of compared with chemotherapy alone (moderate certainty).
1 finding from 1 review
- Molecular‐targeted first‐line therapy for advanced gastric cancer 2016 · Cochrane Headline outcomes onlyOR 2.23 [1.27, 3.92]5 studies · 2290 participantsModerate